The World Journal of Biological Psychiatry · 2010 · 56 citations · 58 references
Life SciencesBiochemistryPsychiatryMolecular NeurobiologyMolecular NeuroscienceProteomicsCerebrospinal Fluid BiomarkersClinical ProteomicsLipoprotein AnalysisProtein ElectrophoresisProteomic ProfilingSchizophrenia Spectrum DisordersCerebrospinal Fluid MarkersDifferential Protein Expression AnalysisFirst-episode SchizophreniaGel ElectrophoresisProtein Analysis In Body FluidsTwo-dimensional ElectrophoresisTwo-dimensional Gel ElectrophoresisWestern Blot Analysis
OBJECTIVES: To identify proteins differentially expressed in schizophrenia patients, we collected 50 microl cerebrospinal fluid from 17 first-episode schizophrenia patients and 10 healthy controls. METHODS: Their proteins were separated by two-dimensional gel electrophoresis without using any depletion method and identified by mass spectrometry. RESULTS: Approximately 550 spots were detected, six of which had significantly different intensities in schizophrenia compared to control specimens. We were able to validate in individual samples the upregulation of apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase by Western blot analyses and detect the downregulation of transthyretin, TGF-beta receptor type-1 and coiled-coil domain-containing protein 3 precursor. CONCLUSIONS: These findings may help to elucidate the disease mechanisms and confirm the hypothesis of disturbed cholesterol and phospholipid metabolism in schizophrenia, and thus reveal the final role players. Moreover, a grouped protein expression analysis of apolipoprotein E, apolipoprotein A-I, and prostaglandin-H2 D-isomerase in cerebrospinal fluid from patients might be a potential diagnostic tool for schizophrenia.
58
Jean Endicott · Archives of General Psychiatry · 1976 · 5K citations
CNS Synaptogenesis Promoted by Glia-Derived Cholesterol
Daniela H. Mauch, Karl Nägler, Stefan Schumacher et al. · Science · 2001 · 1.7K citations